Business Wire

The PROSUME Energy Foundation Presents a Blockchain-Based Platform That Will Foster the Peer-to-Peer Energy Exchanges

Jaa

Rethinking the actual energy models, looking forward a network of communities and new ways to share sources: these are the ideas behind the Swiss PROSUME Energy Foundation, founded in Zug, the heart of the Crypto Valley, by professionals with a strong and long-time experience in the energy sector as well as in the blockchain softwares.

The Foundation has developed a new revolutionary platform to exchange electricity from renewable and fossil sources. It connects independent power producers, consumers, innovative utility companies and energy communities in a locally shared market where each peer is free to interact in a multi-tenant ecosystem.

The mission of the Foundation is to promote decentralizing power models and empower energy communities through the blockchain software technology and through the implementation of peer to peer energy exchange policies targeting possible solutions for all the existing physical and legal energy framework barriers, investing in Research & Development to offer innovative hardware and IoT-devices related to smart metering, smart grid, energy routers and devices.

PROSUME is based over 3 main pillars: decentralization, digitalization and decarbonisation. Blockchain has been considered the perfect tool to achieve the mission of the Foundation because this disruptive technology combines IT with cryptography and governance principles to create a new safer, more resilient and transparent place where everyone could be independent in choosing his own energy sources.

In order to support its project and mission, Prosume is launching a pre-ICO based on upgradeable ERC20 derivate Token named PEF Token on the Ethereum platform, the industry standard for issuing custom digital assets and smart contracts. Its ease in the use by everyone let Ethereum be the perfect solution for an Initial Coin Offering.

Because the platform deals with many of today’s problems and opportunities related to the energy sharing sector, like support for regulation frameworks, fair policy pricing, network balancing, smart payment and smart billing, the advanced features and active ecosystem of Ethereum make it the natural fit for Prosume. Ethereum’s ability to deploy smart contracts enables complex issuance rules for cryptocurrencies, digital financial contracts, and automated incentive structures.

“We strongly believe in the sharing energy model based on the peer to peer exchange system, for this reason PROSUME platform has as its main goal to be the most innovative place to develop energy communities, in order to give everyone the possibility to exchange energy in a more transparent, traceable, accessible, flexible, resilient and sustainable wayaffirms Alfredo Giardina, Co-founder of PROSUME Energy Foundation.

The pre-ICO will start on the 27th of September 2017, providing early adopters and strategic partners the chance to exchange tokens for ETH or BTC or LTC with a significant Bonus, starting at 47 %.
The main ICO will last for 4 weeks, with a different bonus rate every week limited to a certain size.

The ERC20 token interface allows for the deployment of a standard token that is compatible with the existing infrastructure of the Ethereum ecosystem, such as development tools, wallets, and exchanges.

The token accepted for the pre-ICO are ETH (ethereum) BTC (bitcoin) and LTC (litecoin).

The PEF Token will be upgradeable using an opt-in mechanism for future upgrades and it will be non-transferable until the ICO ends. The ICO contract will have a limit of 50000 PEF Tokens in order to facilitate a uniform ICO process. Multiple transactions are allowed.

Several energy companies from all around Europe have already showed a keen interest in this project and PROSUME is now negotiating eight different pilot projects. The upcoming pre-ICO will be the perfect opportunity to let everyone take active part to this great revolution. We really do believe in the power of sharing energy as this is the best way to empower yourself and gain your independence” continues Mr. Giardina.

Contact information

Prosume
Giovanni Quaglino
pressoffice@prosume.io

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 23:37Tiedote

Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f

Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference19.4.2018 18:45Tiedote

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced that Rodolphe Hajj, Ph.D., the Company’s Chief Pharmacology Officer, will present at the 8th Annual Global Orphan Drug Conference. The presentation will take place as follows: Date & Time: Wednesday April 25th at 4:40 pm EST Title: “Next generation drug repurposing using network pharmacology to develop new therapeutic entities for rare diseases” Venue: Gaylord National Harbor Hotel, Oxon Hill, MD, U.S. Pharnext’s team will also attend the 2018 American Academy of Neurology Annual Meeting as a first-time exhibitor (booth 908). The meeting will take place on April 21-27, 2018 in Los Angeles, CA, U.S. If you are interested in meeting the Pharnext management team during these events, please send an email to contact@pharnext.com. About Pharnext Pharne

New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices19.4.2018 18:01Tiedote

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419005949/en/ Masimo Radical-7® with SpHb® and RD rainbow SET™ Sensor (Photo: Business Wire) In the study, Prof. Baricchi and colleagues in the Transfusion Medicine Unit, AUSL-IRCCS of Reggio Emilia and at the Department of Medicine and Surgery at the University of Parma, Italy, sought to evaluate the appropriateness of post-operative RBC transfusion over a three-year period (2013-2015), before and after implementation of a patient blood managem

Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform19.4.2018 17:06Tiedote

Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. The CRO today announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities. Synteract’s leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract’s longstanding, specialized expertise in these complex areas of clinical research. Synteract CEO Steve Powell says, “By aligning operational excel

Nel ASA: Receives Additional Purchase Order from Nikola19.4.2018 17:00Tiedote

Nel ASA (Nel, OSE: NEL) has received a USD 5.5 million purchase order from Nikola Motor Company (Nikola), as part of the previously announced hydrogen stations. “We are very proud to announce that we have received an additional order from Nikola related to the electrolyzer and fueling solution for their prototype trucks. The order marks a strengthening of our partnership and is a recognition of the level of competence our team and hydrogen solutions can offer. We look forward to supplying the demo stations, which will lay the groundwork for the world’s largest, most efficient network of low-cost hydrogen production and fueling sites,” says Jon André Løkke, Chief Executive Officer of Nel. On November 15, 2017, Nikola and Nel announced the exclusive partnership and a purchase order for two so-called demo hydrogen refueling stations for Nikola's fleet of prototype hydrogen trucks. The partnership aims at developing low-cost, renewable hydrogen production and fueling sites for the potentia

Voith and Franka Emika Form a Strategic Partnership19.4.2018 16:39Tiedote

The technology company Voith and the Munich-based robotics company Franka Emika have entered into a strategic partnership. Part of the strategic partnership is the establishment of a new joint venture called Voith Robotics – A Voith and Franka Emika Company. The company, with headquarters in Munich, is to become a global system supplier for robot-assisted automation in the digital age. Voith Robotics will offer self-teaching lightweight robots made by Franka Emika, along with software solutions, apps, services and process consulting, to customers in various industries and markets throughout the world. As part of the strategic partnership Voith will also have a direct stake in Franka Emika, thus emphasizing the long-term and strategic commitment by the two companies to cooperation. Martin Scherrer, formerly a member of the Board of Management of Voith Paper, will be the new chief executive officer of Voith Robotics, which is to be managed by Voith. The still very young market for collab

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme